{
    "pmcid": "9957715",
    "qa_pairs": {
        "How can insights from AFM inform the design of nanobodies targeting SARS-CoV-2?": [
            "By identifying potential binding sites and interaction mechanisms.",
            "By predicting viral genome sequences.",
            "By designing small molecule inhibitors.",
            "By identifying viral replication pathways."
        ],
        "What is AlphaFold-Multimer (AFM) primarily designed to predict?": [
            "Protein-protein interactions by leveraging co-evolutionary data from multiple sequence alignments (MSAs).",
            "Single protein structures using deep learning algorithms.",
            "RNA secondary structures using sequence alignment data.",
            "Small molecule binding sites on protein surfaces."
        ],
        "What is a noted limitation of AFM predictions according to the paper?": [
            "Predictions are limited to a single conformational state, which may not capture the full dynamic range of protein interactions.",
            "Predictions are limited to small proteins, making it unsuitable for large protein complexes.",
            "Predictions are only accurate for membrane-bound proteins, not soluble proteins.",
            "Predictions are limited to nucleic acid interactions, not protein-protein interactions."
        ],
        "What potential mechanism of action was suggested for FHR1 in the study?": [
            "Inhibiting MAC formation by blocking C5 activation and C9 polymerization.",
            "Enhancing MAC formation by promoting C5 activation and C9 polymerization.",
            "Inhibiting MAC formation by blocking C3 activation and C7 polymerization.",
            "Enhancing MAC formation by promoting C3 activation and C7 polymerization."
        ],
        "Which complement components were modeled with FHR1 and its synthetic derivatives using AFM?": [
            "C3, C5, C7, C9",
            "C1, C2, C4, C6",
            "C3, C4, C6, C8",
            "C1, C3, C5, C8"
        ]
    }
}